EMEA-002343-PIP01-18

Key facts

Active substance
  • Diphtheria toxoid
  • tetanus toxoid
  • pertussis toxoid
  • pertussis filamentous haemagglutinin
  • pertactin
Therapeutic area
Infectious diseases
Decision number
P/0231/2019
PIP number
EMEA-002343-PIP01-18
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Prevention of infectious diseases caused by Corynebacterium diphtheriae, Clostridium tetani and Bordetella pertussis
Route(s) of administration
Intramuscular use
Contact for public enquiries
Vakzine Projekt Management GmbH

Tel.++4951116990819
E-mail: info@vakzine-manager.de

Decision type
RP: decision refers to a refusal on a proposed Paediatric Investigation Plan

Decision

How useful was this page?

Add your rating